Vivos Inc. (OTCMKTS:RDGL) Sees Significant Decline in Short Interest

Vivos Inc. (OTCMKTS:RDGL) was the target of a significant decrease in short interest in the month of February. As of February 15th, there was short interest totalling 5,800 shares, a decrease of 67.8% from the January 31st total of 18,000 shares. Based on an average trading volume of 2,339,200 shares, the days-to-cover ratio is presently 0.0 days.

Vivos Price Performance

Shares of RDGL stock traded down $0.00 during trading hours on Friday, hitting $0.11. The stock had a trading volume of 1,219,055 shares, compared to its average volume of 1,358,471. The firm has a market capitalization of $49.00 million, a PE ratio of -10.80 and a beta of 0.89. Vivos has a twelve month low of $0.05 and a twelve month high of $0.26. The stock’s 50 day moving average is $0.13 and its 200 day moving average is $0.13.

Vivos Company Profile

Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals.